RAPT Therapeutics Soars 10.28% on Positive Earnings Outlook

On March 27, 2025, RAPT Therapeutics' stock surged by 10.28% in pre-market trading, indicating a strong start to the day's trading session.

RAPT Therapeutics, Inc. is expected to see a decline in its stock price over the next three months, with analysts predicting a 17% drop. This forecast is based on the current short-term trend and market conditions.

The company's earnings are projected to improve next year, with earnings per share (EPS) expected to rise from -$2.14 to -$1.35. This positive outlook on earnings growth could influence investor sentiment and potentially impact the stock price.